Israeli biomedical company Cannabotech launches into the UK with the opening of its first retail store at Westfield London.  The launch realises Cannabotech’s ambitious plan to revolutionise the UK’s health and wellbeing retail experience and grow the UK CBD market.

Investing £800k into its 100 square metre Westfield store, Cannabotech is adopting a new approach to the preventative care retail category. Instead of focusing on the traditional one-size-fits-all purchasing model, Cannabotech is utilising state of the art technology together with unique testing and analysis capabilities to provide visitors with precise, personalised and data-driven product recommendations.

Cannabotech’s store at Westfield brings to life the company’s “My Being” approach and will offer visitors the opportunity to:

  • Use one of four specially designed in-store facial scanners. Using advanced AI technology, the scan analyses a customer’s physiological and mental health measures in just 40 seconds.
  • Have a free one-to-one instore consultation with a qualified naturopath to discuss their preventative health needs.
  • Use the holographic interactive table, offering an interactive way to explore the M2CBD formula benefits and our preventative care solutions.
  • Purchase Cannabotech’s extensive product range of more than 30 products including tinctures, topicals and capsules which provide solutions to today’s modern day health concerns, such as stress, sleep and joint pain. Its unique, patented M²CBD formula, created after years of scientific research, combines premium pharmaceutical grade CBD with medicinal mushrooms for a supercharged, integrative effect on health and wellbeing.

Cannabotech’s unique technology driven approach to preventative health signals a new era for the health and wellbeing retail space, not just in London but across the UK as Cannabotech plans to open a further three destination retail stores in over the next six months.

Cannabotech was established in 2019, following a successful £10 million investment round in Israel. With ambitious growth plans and aims of reaching a £100m global sales target in the next five years, Cannabotech’s team of leading scientists and academics chose to launch in the UK, identifying it as the fastest growing CBD market in Europe and second in the world after the US.

Elchanan Shaked, Cannabotech’s CEO and Chairman comments, “We are a biomedical company that focus on the two main drivers of the healthcare industry – preventative care and integrative solutions.  The UK was a natural choice for us given that it’s the largest & fastest growing CBD market in Europe, and has both a well-established e-comm market and regulated regulation.  Westfield has the strongest “purchasing power” in London and we’re confident that we’re bringing something unique to retail – our first-class experience coupled with our advanced technology will offer visitors an experience that they can’t get anywhere else.”

Dr Gemma Newman comments, “This new approach to health and wellbeing from Cannabotech marks an exciting era for consumers who not only want to feel supported on their healthcare journey, but also understand the reasons why they have been recommended a particular product. Cannabotech’s store provides customers with all this and more, offering a truly transparent and unique data driven approach to a consumer’s  health concerns.”

Jacinta Rowsell, General Manager, Westfield London, says, “Our How We Shop report revealed that over half (52%) of UK consumers are interested in health services and experiences offered in-store or at shopping centres and we’re pleased to continue diversifying our offering for visitors at Westfield London through Cannabotech’s innovative approach to wellbeing.”

For further information on Cannabotech please visit

May 2023 issue

2023 A1 Buyers Guide